Standard Biotools Inc.
LAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001162194
No open-market purchases or sales by Standard Biotools Inc. insiders were filed in the last 90 days; 143 institutions reported holding it in 13F filings for Q2 2026, worth $243.6M in total; Viking Global Investors is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Standard Biotools Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 86 | 65 | −21 |
| Shares | 43.9M | 38.6M | −5.24M (−11.9%) |
| Value | $70.2M | $42.5M | −$27.7M (−39.4%) |
New holders (4)
Institutions that held Standard Biotools Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 162,000 | $178.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 18,141 | $20.0K | 0.00% |
| Simplex Trading, LLC | 10,102 | $11.0K | 0.00% |
| Brown Brothers Harriman & Co | 2,307 | $3.00K | 0.00% |
Sold out (25)
Institutions that held Standard Biotools Inc. at the end of Q2 2022 and filed for Q3 2022 without it.